Quadrature Capital’s LifeMD LFMD Stock Holding History

Quadrature Capital’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-11,545	Closed	-$157K	–	1294
2025 Q2	$157K	Sell	11,545 -31,484	-73%	-$297K	﹤0.01%	850
2025 Q1	$234K	Buy	+43,029	New	+$244K	0.01%	821

Other funds holding LFMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Quadrature Capital's LFMD Position: Q3 2025 in Review

Quadrature Capital sold out of LifeMD (LFMD) in Q3 2025, closing a stake of 11,545 shares — an estimated $157K sold.

Quadrature Capital first reported a position in LFMD in Q1 2025 and held it in 2 quarters. The position peaked at $234K in Q1 2025. 114 funds tracked by Wall St. Rank hold LFMD as of Q3 2025.

Quadrature Capital reported no remaining LifeMD position as of Q3 2025 after selling out during the quarter.
Quadrature Capital sold 11,545 LifeMD shares in Q3 2025, an estimated $157K.
Quadrature Capital first reported a position in LifeMD in Q1 2025 and held it in 2 quarters.
Quadrature Capital's LifeMD position peaked at $234K in Q1 2025.
114 funds tracked by Wall St. Rank held LifeMD as of Q3 2025.

Based on Quadrature Capital's 13F filing for Q3 2025, filed 13 Nov 2025.